Following the passage of ObamaCare, several of the smartest people I know claimed that the bill was actually written by and for the drug and insurance companies rather than “the people” as Obama had claimed. My friend and orthopedic surgeon Dave Janda wrote an excellent piece that I published titled: Thoughts on Obamacare from a Surgeon and Friend.
In recent days it has emerged that Liz Fowler, who is said to have been one of the key architects of ObamaCare, is doing what any good revolving door crony capitalist would do. She is moving to the private sector to receive her payoff. Trudy Lieberman of the Columbia Journal Review explains that:
Revolving door on Wall Street. Check. Revolving door at the Pentagon. Check. Revolving door in Healthcare. Check mate. Welcome to America. Check your freedom at the door.Herewith is a brief Fowler curriculum vitae: In 2001 she had a plum job as chief counsel for the Senate Finance Committee, which deals with healthcare bills. As Greenwald’s old Salon post notes, her biography says she “played a key role” in the 2003 Medicare prescription drug law that created a new senior drug benefit—a benefit provided via private insurers, not the government, as is the case for other Medicare benefits. A few years later she landed a position at WellPoint as a vice president overseeing the giant insurer’s lobbying activities.
Fowler then returned to Senate Finance in 2008 to work for Sen. Max Baucus, who chaired the committee, which was becoming Action Central for health reform. Fowler and Baucus pretty much wrote the bill that became Obamacare—and which, we should note, did not include a proposed “public option,” which was popular with ordinary people but not the insurance companies that lobbied hard to make sure it was out of the mix.
Then this week Politico’s Dave Levinthal and Anna Palmer had a scoop: Fowler is returning to the private world, this time to a senior level position leading global health policy at Johnson & Johnson’s government affairs and policy group.
Read the full article here.
No comments:
Post a Comment